Product Information

METFORMIN HCL 850 MG TABLET is a generic product labeled by Ascend Laboratories, LLC, priced at $0.0257 per EA under NDC 67877056201. Its NADAC has been published 476 times since Oct 11, 2017.

FDA first approved this application on Apr 22, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METFORMIN HCL 850 MG TABLET

Metformin HCl
$0.0257per EA

Strength

850 mg/1

NDC

67877056201

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

METFORMIN HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA090564

FDA Approved

4/22/2010

TE Code

AB

On Market Since

2/6/2017

Pharmacological Classes

Biguanide
Biguanides

Price Statistics

The NADAC for METFORMIN HCL 850 MG TABLET has been published 476 times since Oct 11, 2017, and over the history we have for it it has declined 20.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0257 per EA
All-time high$0.0325 (Oct 11, 2017)
All-time low$0.0196 (May 22, 2024)
52-week high$0.0257
52-week low$0.0227
Median price$0.0278
Average price$0.0271
Largest weekly change+26.0% (Jun 19, 2024)
Weeks tracked476
Tracking sinceOct 11, 2017

Price History

1W

+5.3%

1M

+7.1%

3M

+7.6%

6M

+3.5%

1Y

+13.2%

3Y

-2.9%

5Y

-5.2%

All

-20.9%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of METFORMIN HCL 850 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for METFORMIN HCL 850 MG TABLET, manufactured by Ascend Laboratories, LLC, is $0.0257 per EA (NDC 67877056201), effective Nov 18, 2026.

How has the price of METFORMIN HCL 850 MG TABLET changed over time?

Over the history we have for it, the NADAC for METFORMIN HCL 850 MG TABLET has declined 20.9%. It has been tracked across 476 weekly CMS publications since Oct 11, 2017.

What are the highest and lowest recorded NADAC prices for METFORMIN HCL 850 MG TABLET?

Since Oct 11, 2017, the NADAC for METFORMIN HCL 850 MG TABLET has ranged from a low of $0.0196 (May 22, 2024) to a high of $0.0325 (Oct 11, 2017), with a median of $0.0278 per EA.

Are there cheaper alternatives to METFORMIN HCL 850 MG TABLET?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METFORMIN HCL 850 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures METFORMIN HCL 850 MG TABLET?

METFORMIN HCL 850 MG TABLET (NDC 67877056201) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.